US-based Subsense has raised $10m, bringing the brain-computer interface (BCI) developer’s total funding to $27m since it ...

The US Food and Drug Administration (FDA) has cleared Flow Neuroscience’s at-home, non-drug depression treatment, making it ...

Medline has filed for an initial public offering (IPO) seeking to raise up to $5.37bn, a figure that would leave the medical ...

Impulse Dynamics has secured over $158m in funding aimed at supporting its commercialisation efforts and progressing its ...

The Food and Drug Administration (FDA) has granted 510(k) clearance for Vesalio’s enVast clot retriever, paving the way for ...

Guardant Health and AI technology firm Trial Library have formed a strategic partnership aimed at improving access to cancer ...

HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two ...

Lunit has announced the submission of a 510(k) premarket notification seeking clearance from the US FDA for its breast cancer ...

The US Food and Drug Administration (FDA) has launched Technology-Enabled Meaningful Patient Outcomes (TEMPO), a pilot that ...

Nitinotes has commenced its US investigational device exemption (IDE) Endoscopic Automated Sleeve Evaluation (EASE) Clinical ...

Aquapass has secured marketing approval in Israel for the AQUAPASS System, intended for patients experiencing fluid overload.